Indo Borax & Chemicals profit and loss

Latest FY26

Revenue: ₹215cr+22.9% on FY25
EBITDA: ₹44.2cr−3.8% on FY25
Net profit: ₹50.3cr+18.3% on FY25
EPS: ₹15.67+18.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	232	215	175	191	225	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	15.0	15.4	15.6	11.8	7.2
	247	231	191	203	232
	122	114	81.8	102	98.7
	2.8	2.8	0.2	0.0	0.0
	−3.2	−3.6	−0.1	0.4	9.5
	19.5	17.8	14.3	11.9	13.6
	0.1	0.1	0.2	0.0	0.1
	2.6	3.2	2.6	2.3	1.6
	39.6	39.9	33.2	34.3	41.3
	183	175	132	151	165
	51.7	44.2	45.9	42.7	61.9
	49.1	41.0	43.2	40.5	60.4
Profit
	64.0	56.4	58.7	52.2	67.5
	10.1	10.1	0.0	0.0	1.5
	74.1	66.5	58.7	52.2	69.0
	19.4	18.1	15.3	13.8	18.0
	−1.6	−1.8	0.9	−0.5	0.3
	17.8	16.2	16.2	13.3	18.3
	56.3	50.3	42.5	39.0	50.7
	56.3	50.3	42.5	39.0	50.7
	5.4	4.1	2.7	2.6	0.4
	61.7	54.4	45.2	41.6	51.1
	—	54.4	—	41.6	—
Per share
	₹17.56	₹15.67	₹13.25	₹12.15	₹15.80
	₹17.56	₹15.67	₹13.25	₹12.15	₹15.80
Other comprehensive income — detail
	5.4	4.1	2.7	—	—
	5.4	4.4	2.3	2.9	0.4
	0.0	0.3	−0.5	—	—
	—	—	—	0.3	−0.0
	—	—	—	41.6	—
Per share — as-filed variants
	₹17.56	₹15.67	₹13.25	₹12.15	₹15.80
	₹17.56	₹15.67	₹13.25	₹12.15	₹15.80
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	111	102	93.3	88.9	117
	47.7%	47.3%	53.3%	46.5%	51.9%
Adjusted (ex-exceptional items) — derived
	64.0	56.4	58.7	52.2	67.5
	10.1	10.1	0.0	0.0	1.5
	48.6	42.6	42.5	39.0	49.6
	₹15.16	₹13.28	₹13.25	₹12.15	₹15.46

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INDOBORAX₹407.30

Indo Borax & Chemicals Limited

· Chemicals

Annual Quarterly₹ CrorePeersSPLPETRO SUMICHEM IGPL OAL PCBL PARADEEP SHREEPUSHK JUBLINGREAMcap ₹1,307 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	225.1	191.3	175.3	215.5	232.2
Other Income	7.2	11.8	15.6	15.4	15.0
Total Income	232.3	203.1	190.9	230.9	247.2
Expenses
+ Cost of Materials Consumed	98.7	102.0	81.8	114.3	121.8
+ Purchases of Stock-in-Trade	0.0	0.0	0.2	2.8	2.8
+ Changes in Inventories	9.5	0.4	-0.1	-3.6	-3.2
+ Employee Benefit Expense	13.6	11.9	14.3	17.8	19.5
+ Finance Costs	0.1	0.0	0.2	0.1	0.1
+ Depreciation & Amortisation	1.6	2.3	2.6	3.2	2.6
+ Other Expenses	41.3	34.3	33.2	39.9	39.6
Total Expenses	164.8	150.8	132.2	174.5	183.2
EBITDA	61.9	42.7	45.9	44.2	51.7
EBIT	60.4	40.5	43.2	41.0	49.1
Profit
PBT before Exceptional Items	67.5	52.2	58.7	56.4	64.0
+ Exceptional Items	1.5	0.0	0.0	10.1	10.1
Pretax Income	69.0	52.2	58.7	66.5	74.1
+ Current Tax	18.0	13.8	15.3	18.1	19.4
+ Deferred Tax	0.3	-0.5	0.9	-1.8	-1.6
Tax Expense	18.3	13.3	16.2	16.2	17.8
Net Income	50.7	39.0	42.5	50.3	56.3
+ Net Income — Continuing Ops	50.7	39.0	42.5	50.3	56.3
+ Other Comprehensive Income	0.4	2.6	2.7	4.1	5.4
Total Comprehensive Income	51.1	41.6	45.2	54.4	61.7
Net Income to Common	—	41.6	—	54.4	—
Per Share
Basic EPS	15.80	12.15	13.25	15.67	17.56
Diluted EPS	15.80	12.15	13.25	15.67	17.56
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	2.7	4.1	5.4
+ Items NOT to be Reclassified to P&L	0.4	2.9	2.3	4.4	5.4
+ Tax on Items NOT to be Reclassified	—	—	-0.5	0.3	0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	0.3	—	—	—
Comprehensive Income — Owners of Parent	—	41.6	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	15.80	12.15	13.25	15.67	17.56
Diluted EPS — Continuing Operations	15.80	12.15	13.25	15.67	17.56
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	116.8	88.9	93.3	101.9	110.9
Gross Margin %	51.90	46.48	53.26	47.30	47.74
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	67.5	52.2	58.7	56.4	64.0
− Exceptional Items (reconciliation)	1.5	0.0	0.0	10.1	10.1
Net Income Adj (tax-effected)	49.6	39.0	42.5	42.6	48.6
EPS Adj	15.46	12.15	13.25	13.28	15.16
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	—	3.2	3.2	3.2	3.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.